What This Means If You Are a Cost-Conscious GLP-1 User Right Now The biosimilar future is real, but it is not your present reality if you are in the United States
The Semaglutide market is expanding in Europe due to the rising prevalence of these disorders and the increased demand for effective treatment options
Add 2 cups of mixed greens on the side to increase your vegetable intake
Thats roughly 4% of the 3,866 calls related to all GLP-1 medications in that time frame, but its up from the 32 compounded GLP-1 exposure calls in all of 2023
Prescription volumes have surged, with GLP-1 users rising from 745 per 100,000 individuals in 2018 to 3,572 per 100,000 in 2023, indicating a 4.7x increase in adoption
When paired with education, nutrition guidance, and realistic expectations, it becomes less about losing weight and more about regaining control and confidence